Search research articles
Contact Us
Filters
Showing results (61-70 of 95) with videos related to
Page
of 10
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
December 8, 2020
PBPK Model of Coproporphyrin I: Evaluation of the Impact of SLCO1B1 Genotype, Ethnicity, and Sex on its Inter-Individual Variability
Hiroyuki Takita, Shelby Barnett, Yueping Zhang, et al.
Journal of Clinical Pharmacology
|
October 15, 2013
Precision criteria to derive sample size when designing pediatric pharmacokinetic studies: which measure of variability should be used?
Farzaneh Salem, Kayode Ogungbenro, Pavan Vajjah, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 13, 2025
Mathematical Modeling of Neuroinflammation in Neurodegenerative Diseases
Alex Foster-Powell, Amin Rostami-Hodjegan, Guy Meno-Tetang, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 19, 2024
Hierarchical cluster analysis and nonlinear mixed-effects modelling for candidate biomarker detection in preclinical models of cancer
David Hodson, Hitesh Mistry, James Yates, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 11, 2021
Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters
Amais Ahmad, Kayode Ogungbenro, Annett Kunze, et al.
Clinical Pharmacology and Therapeutics
|
December 16, 2017
Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B-Mediated Drug-Drug Interactions Using Population Pharmacokinetic Modeling and Simulation
Shelby Barnett, Kayode Ogungbenro, Karelle Ménochet, et al.
The AAPS Journal
|
January 14, 2022
In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
Yukiko Murata, Sibylle Neuhoff, Amin Rostami-Hodjegan, et al.
The AAPS Journal
|
February 5, 2020
Global Sensitivity Analysis of the Rodgers and Rowland Model for Prediction of Tissue: Plasma Partitioning Coefficients: Assessment of the Key Physiological and Physicochemical Factors That Determine Small-Molecule Tissue Distribution
Estelle Yau, Andrés Olivares-Morales, Michael Gertz, et al.
Journal of Clinical Pharmacology
|
June 16, 2017
Population Pharmacokinetics of Imatinib in Nigerians With Chronic Myeloid Leukemia: Clinical Implications for Dosing and Resistance
Babatunde Ayodeji Adeagbo, Tiwalade Adewale Olugbade, Muheez Alani Durosinmi, et al.
Annals of the Rheumatic Diseases
|
June 7, 2019
Development and validation of a methotrexate adherence assay
James Bluett, Isabel Riba-Garcia, Suzanne M M Verstappen, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 95) with videos related to
Sort By:
Page
of 10
CPT: Pharmacometrics & Systems Pharmacology
|
December 8, 2020
PBPK Model of Coproporphyrin I: Evaluation of the Impact of SLCO1B1 Genotype, Ethnicity, and Sex on its Inter-Individual Variability
Hiroyuki Takita, Shelby Barnett, Yueping Zhang, et al.
Journal of Clinical Pharmacology
|
October 15, 2013
Precision criteria to derive sample size when designing pediatric pharmacokinetic studies: which measure of variability should be used?
Farzaneh Salem, Kayode Ogungbenro, Pavan Vajjah, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 13, 2025
Mathematical Modeling of Neuroinflammation in Neurodegenerative Diseases
Alex Foster-Powell, Amin Rostami-Hodjegan, Guy Meno-Tetang, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 19, 2024
Hierarchical cluster analysis and nonlinear mixed-effects modelling for candidate biomarker detection in preclinical models of cancer
David Hodson, Hitesh Mistry, James Yates, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 11, 2021
Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters
Amais Ahmad, Kayode Ogungbenro, Annett Kunze, et al.
Clinical Pharmacology and Therapeutics
|
December 16, 2017
Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B-Mediated Drug-Drug Interactions Using Population Pharmacokinetic Modeling and Simulation
Shelby Barnett, Kayode Ogungbenro, Karelle Ménochet, et al.
The AAPS Journal
|
January 14, 2022
In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
Yukiko Murata, Sibylle Neuhoff, Amin Rostami-Hodjegan, et al.
The AAPS Journal
|
February 5, 2020
Global Sensitivity Analysis of the Rodgers and Rowland Model for Prediction of Tissue: Plasma Partitioning Coefficients: Assessment of the Key Physiological and Physicochemical Factors That Determine Small-Molecule Tissue Distribution
Estelle Yau, Andrés Olivares-Morales, Michael Gertz, et al.
Journal of Clinical Pharmacology
|
June 16, 2017
Population Pharmacokinetics of Imatinib in Nigerians With Chronic Myeloid Leukemia: Clinical Implications for Dosing and Resistance
Babatunde Ayodeji Adeagbo, Tiwalade Adewale Olugbade, Muheez Alani Durosinmi, et al.
Annals of the Rheumatic Diseases
|
June 7, 2019
Development and validation of a methotrexate adherence assay
James Bluett, Isabel Riba-Garcia, Suzanne M M Verstappen, et al.
Page
of 10